Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Ollie Hinkle Foundation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 19, 2024 9:34am
46 Views
Post# 36185674

RE:Ollie Hinkle Foundation

RE:Ollie Hinkle Foundation Interesting repost and reaction like  
Background Image
 

Nick Tsergas

 
Health News Editor, CanadaHealthwatch.ca
Ottawa, Ontario, Canada  Contact info
Canada Healthwatch
  • 1,208 followers 
  • 500+ connections
  •  




 
View my newsletter
Ventripoint continues to move ahead with its amazing technology that allows incredibly detailed images of the heart to be taken with ultrasound, offering a fast and inexpensive alternative to MRIs (which are also great and essential).

Ventripoint, which is now being used in major hospitals, is particularly useful in treating infants and children, who may not be ready for the intense experience of MRIs. In fact, this Canadian-made technology is now often used in the care of children in Europe, Canada and the U.S.

If you want to see a real-life use of AI in health care, check it out: www.ventripoint.com
Best wishes to Samih as he continues on his life journey after receiving the Fontan procedure. Our technology roadmap includes incorporating univentricular and HLHS cases into VMS+ to better support patients such as Samih, and working with agencies such as the Ollie Hinkle Foundation to transform the future of paediatric heart care.

https://lnkd.in/gpbfJnqa

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities